Advertisement

Food-Induced Anaphylaxis: an Update

  • Christopher P. Parrish
  • Heidi Kim
Anaphylaxis and Drug Allergy (DA Khan and M Castells, Section Editors)
Part of the following topical collections:
  1. Topical Collection on Anaphylaxis and Drug Allergy

Abstract

Purpose of Review

This review aims to provide an update of recent advances in the epidemiology, clinical features and diagnosis, and management of food-induced anaphylaxis (FIA).

Recent Findings

Food allergy prevalence and FIA rates continue to rise, but FIA fatalities are stable. Basophil and mast cell activation tests promise more accurate identification of food triggers. Oral, sublingual, and epicutaneous immunotherapy can desensitize a significant portion of subjects. Epinephrine use for FIA remains sub-optimal.

Summary

As the burden of food allergy continues to increase, it appears that the corresponding increase in research focused on this epidemic is beginning to bear fruit. The stable number of FIA fatalities in the face of an ongoing epidemic indicates lives have already been saved. The emergence of new diagnostic tests and interventional therapies may transform the management of FIA in the coming years.

Keywords

Food allergy Anaphylaxis Epinephrine Peanut allergy Oral immunotherapy 

Notes

Compliance with Ethical Standards

Conflict of Interest

Dr. Parrish reports personal fees and non-financial support from Pharmacy Times Continuing Education, non-financial support from DBV Technologies, and non-financial support from Aimmune Therapeutics, outside the submitted work. Dr. Kim declares that she has no conflict of interest.

Human and Animal Rights and Informed Consent

This article does not contain any studies with human or animal subjects performed by any of the authors.

References

Papers of Particular Interest, Published Recently, Have Been Highlighted as: • Of Importance, •• Of Major Importance

  1. 1.
    Sampson HA, Munoz-Furlong A, Campbell RL, Adkinson NF Jr, Bock SA, Branum A, et al. Second symposium on the definition and management of anaphylaxis: summary report––second National Institute of Allergy and Infectious Disease/Food Allergy and Anaphylaxis Network symposium. J Allergy Clin Immunol. 2006;117(2):391–7.  https://doi.org/10.1016/j.jaci.2005.12.1303. CrossRefPubMedGoogle Scholar
  2. 2.
    Greenhawt M. Food allergy quality of life and living with food allergy. Curr Opin Allergy Clin Immunol. 2016;16(3):284–90.  https://doi.org/10.1097/ACI.0000000000000271.CrossRefPubMedGoogle Scholar
  3. 3.
    Cummings AJ, Knibb RC, King RM, Lucas JS. The psychosocial impact of food allergy and food hypersensitivity in children, adolescents and their families: a review. Allergy. 2010;65(8):933–45.  https://doi.org/10.1111/j.1398-9995.2010.02342.x. CrossRefPubMedGoogle Scholar
  4. 4.
    Lau GY, Patel N, Umasunthar T, Gore C, Warner JO, Hanna H, et al. Anxiety and stress in mothers of food-allergic children. Pediatr Allergy Immunol. 2014;25(3):236–42.  https://doi.org/10.1111/pai.12233. CrossRefPubMedGoogle Scholar
  5. 5.
    Sicherer SH, Noone SA, Munoz-Furlong A. The impact of childhood food allergy on quality of life. Ann Allergy Asthma Immunol. 2001;87(6):461–4.  https://doi.org/10.1016/S1081-1206(10)62258-2.CrossRefPubMedGoogle Scholar
  6. 6.
    Rona RJ, Keil T, Summers C, Gislason D, Zuidmeer L, Sodergren E, et al. The prevalence of food allergy: a meta-analysis. J Allergy Clin Immunol. 2007;120(3):638–46.  https://doi.org/10.1016/j.jaci.2007.05.026.
  7. 7.
    Branum AM, Lukacs SL. Food allergy among children in the United States. Pediatrics. 2009;124(6):1549–55.  https://doi.org/10.1542/peds.2009-1210.CrossRefPubMedGoogle Scholar
  8. 8.
    Osborne NJ, Koplin JJ, Martin PE, Gurrin LC, Lowe AJ, Matheson MC, et al. Prevalence of challenge-proven IgE-mediated food allergy using population-based sampling and predetermined challenge criteria in infants. J Allergy Clin Immunol. 2011;127(3):668–76 e1-2.  https://doi.org/10.1016/j.jaci.2011.01.039.
  9. 9.
    Wood RA, Camargo CA Jr, Lieberman P, Sampson HA, Schwartz LB, Zitt M, et al. Anaphylaxis in America: the prevalence and characteristics of anaphylaxis in the United States. J Allergy Clin Immunol. 2014;133(2):461–7.  https://doi.org/10.1016/j.jaci.2013.08.016.
  10. 10.
    Gupta RS, Springston EE, Warrier MR, Smith B, Kumar R, Pongracic J, et al. The prevalence, severity, and distribution of childhood food allergy in the United States. Pediatrics. 2011;128(1):e9–17.  https://doi.org/10.1542/peds.2011-0204.
  11. 11.
    Clark S, Espinola J, Rudders SA, Banerji A, Camargo CA Jr. Frequency of US emergency department visits for food-related acute allergic reactions. J Allergy Clin Immunol. 2011;127(3):682–3.  https://doi.org/10.1016/j.jaci.2010.10.040. CrossRefPubMedGoogle Scholar
  12. 12.
    McWilliam VL, Koplin JJ, Field MJ, Sasaki M, Dharmage SC, Tang MLK, et al. Self-reported adverse food reactions and anaphylaxis in the SchoolNuts study: a population-based study of adolescents. J Allergy Clin Immunol. 2018;141(3):982–90.  https://doi.org/10.1016/j.jaci.2017.09.012.
  13. 13.
    • Ruiz Oropeza A, Lassen A, Halken S, Bindslev-Jensen C, Mortz CG. Anaphylaxis in an emergency care setting: a one year prospective study in children and adults. Scand J Trauma Resusc Emerg Med. 2017;25(1):111.  https://doi.org/10.1186/s13049-017-0402-0. COMMENT: Rare prospective analysis of anaphylaxis epidemiology reported higher rates than other European studies, illustrated low rates of epinephrine use as well. CrossRefPubMedPubMedCentralGoogle Scholar
  14. 14.
    Ma L, Danoff TM, Borish L. Case fatality and population mortality associated with anaphylaxis in the United States. J Allergy Clin Immunol. 2014;133(4):1075–83.  https://doi.org/10.1016/j.jaci.2013.10.029. CrossRefPubMedGoogle Scholar
  15. 15.
    Dyer AA, Lau CH, Smith TL, Smith BM, Gupta RS. Pediatric emergency department visits and hospitalizations due to food-induced anaphylaxis in Illinois. Ann Allergy Asthma Immunol. 2015;115(1):56–62.  https://doi.org/10.1016/j.anai.2015.05.006.CrossRefPubMedGoogle Scholar
  16. 16.
    Xu YS, Kastner M, Harada L, Xu A, Salter J, Waserman S. Anaphylaxis-related deaths in Ontario: a retrospective review of cases from 1986 to 2011. Allergy Asthma Clin Immunol. 2014;10(1):38.  https://doi.org/10.1186/1710-1492-10-38. CrossRefPubMedPubMedCentralGoogle Scholar
  17. 17.
    •• Turner PJ, Gowland MH, Sharma V, Ierodiakonou D, Harper N, Garcez T, et al. Increase in anaphylaxis-related hospitalizations but no increase in fatalities: an analysis of United Kingdom national anaphylaxis data, 1992–2012. J Allergy Clin Immunol. 2015;135(4):956–63 e1.  https://doi.org/10.1016/j.jaci.2014.10.021. COMMENT: Comprehensive epidemiologic study of food-induced anaphylaxis and deaths in the UK over 20-year period.
  18. 18.
    Mullins RJ, Wainstein BK, Barnes EH, Liew WK, Campbell DE. Increases in anaphylaxis fatalities in Australia from 1997 to 2013. Clin Exp Allergy. 2016;46(8):1099–110.  https://doi.org/10.1111/cea.12748. CrossRefPubMedGoogle Scholar
  19. 19.
    Jerschow E, Lin RY, Scaperotti MM, McGinn AP. Fatal anaphylaxis in the United States, 1999–2010: temporal patterns and demographic associations. J Allergy Clin Immunol. 2014;134(6):1318–28 e7.  https://doi.org/10.1016/j.jaci.2014.08.018.CrossRefPubMedPubMedCentralGoogle Scholar
  20. 20.
    •• Turner PJ, Jerschow E, Umasunthar T, Lin R, Campbell DE, Boyle RJ. Fatal anaphylaxis: mortality rate and risk factors. J Allergy Clin Immunol Pract. 2017;5(5):1169–78.  https://doi.org/10.1016/j.jaip.2017.06.031. COMMENT: Excellent review of all recent data on fatal anaphylaxis, including comparison to likelihood of death by other causes. CrossRefPubMedPubMedCentralGoogle Scholar
  21. 21.
    • Umasunthar T, Leonardi-Bee J, Turner PJ, Hodes M, Gore C, Warner JO, et al. Incidence of food anaphylaxis in people with food allergy: a systematic review and meta-analysis. Clin Exp Allergy. 2015;45(11):1621–36.  https://doi.org/10.1111/cea.12477. COMMENT: Systematic review and meta-analysis of FIA.
  22. 22.
    Umasunthar T, Leonardi-Bee J, Hodes M, Turner PJ, Gore C, Habibi P, et al. Incidence of fatal food anaphylaxis in people with food allergy: a systematic review and meta-analysis. Clin Exp Allergy. 2013;43(12):1333–41.  https://doi.org/10.1111/cea.12211.
  23. 23.
    Hu W, Grbich C, Kemp A. When doctors disagree: a qualitative study of doctors’ and parents’ views on the risks of childhood food allergy. Health Expect. 2008;11(3):208–19.  https://doi.org/10.1111/j.1369-7625.2008.00506.x.CrossRefPubMedPubMedCentralGoogle Scholar
  24. 24.
    Sampson HA, Mendelson L, Rosen JP. Fatal and near-fatal anaphylactic reactions to food in children and adolescents. N Engl J Med. 1992;327(6):380–4.  https://doi.org/10.1056/NEJM199208063270603. CrossRefPubMedGoogle Scholar
  25. 25.
    Pumphrey RS, Gowland MH. Further fatal allergic reactions to food in the United Kingdom, 1999–2006. J Allergy Clin Immunol. 2007;119(4):1018–9.  https://doi.org/10.1016/j.jaci.2007.01.021. CrossRefPubMedGoogle Scholar
  26. 26.
    Bock SA, Munoz-Furlong A, Sampson HA. Further fatalities caused by anaphylactic reactions to food, 2001–2006. J Allergy Clin Immunol. 2007;119(4):1016–8.  https://doi.org/10.1016/j.jaci.2006.12.622. CrossRefPubMedGoogle Scholar
  27. 27.
    Pumphrey RS. Fatal posture in anaphylactic shock. J Allergy Clin Immunol. 2003;112(2):451–2.CrossRefPubMedGoogle Scholar
  28. 28.
    Grabenhenrich LB, Dolle S, Moneret-Vautrin A, Kohli A, Lange L, Spindler T, et al. Anaphylaxis in children and adolescents: the European Anaphylaxis Registry. J Allergy Clin Immunol. 2016;137(4):1128–37 e1.  https://doi.org/10.1016/j.jaci.2015.11.015.CrossRefPubMedGoogle Scholar
  29. 29.
    Sheikh A, Shehata YA, Brown SG, Simons FE. Adrenaline for the treatment of anaphylaxis: cochrane systematic review. Allergy. 2009;64(2):204–12.  https://doi.org/10.1111/j.1398-9995.2008.01926.x.CrossRefPubMedGoogle Scholar
  30. 30.
    Bock SA, Muñoz-Furlong A, Sampson HA. Fatalities due to anaphylactic reactions to foods. J Allergy Clin Immunol. 2001;107(1):191–3.  https://doi.org/10.1067/mai.2001.112031.CrossRefPubMedGoogle Scholar
  31. 31.
    Pumphrey RS. Lessons for management of anaphylaxis from a study of fatal reactions. Clin Exp Allergy. 2000;30(8):1144–50.CrossRefPubMedGoogle Scholar
  32. 32.
    Turner PJ, Campbell DE. Epidemiology of severe anaphylaxis: can we use population-based data to understand anaphylaxis? Curr Opin Allergy Clin Immunol. 2016;16(5):441–50.  https://doi.org/10.1097/ACI.0000000000000305.CrossRefPubMedPubMedCentralGoogle Scholar
  33. 33.
    Turner PJ, Baumert JL, Beyer K, Boyle RJ, Chan CH, Clark AT, et al. Can we identify patients at risk of life-threatening allergic reactions to food? Allergy. 2016;71(9):1241–55.  https://doi.org/10.1111/all.12924.
  34. 34.
    Rudders SA, Banerji A, Clark S, Camargo CA Jr. Age-related differences in the clinical presentation of food-induced anaphylaxis. J Pediatr. 2011;158(2):326–8.  https://doi.org/10.1016/j.jpeds.2010.10.017.CrossRefPubMedGoogle Scholar
  35. 35.
    Speakman S, Kool B, Sinclair J, Fitzharris P. Paediatric food-induced anaphylaxis hospital presentations in New Zealand. J Paediatr Child Health. 2018;54(3):254–9.  https://doi.org/10.1111/jpc.13705.CrossRefPubMedGoogle Scholar
  36. 36.
    Kool B, Chandra D, Fitzharris P. Adult food-induced anaphylaxis hospital presentations in New Zealand. Postgrad Med J. 2016;92:640–4.  https://doi.org/10.1136/postgradmedj-2015-133530.CrossRefPubMedGoogle Scholar
  37. 37.
    Ramsey NB, Guffey D, Coleman NE, Davis CM. Characteristics, morbidity, and mortality of anaphylaxis-associated admissions to North American PICUs, 2010–2015. J Allergy Clin Immunol. 2018;141(Supplement 2):AB148–8.Google Scholar
  38. 38.
    Wood RA, Sicherer SH, Vickery BP, Jones SM, Liu AH, Fleischer DM, et al. The natural history of milk allergy in an observational cohort. J Allergy Clin Immunol. 2013;131(3):805–12.  https://doi.org/10.1016/j.jaci.2012.10.060.
  39. 39.
    Savage J, Sicherer S, Wood R. The natural history of food allergy. J Allergy Clin Immunol Pract. 2016;4(2):196–203; quiz 4.  https://doi.org/10.1016/j.jaip.2015.11.024.CrossRefPubMedGoogle Scholar
  40. 40.
    Fernandes RA, Regateiro F, Pereira C, Faria E, Pita J, Todo-Bom A, et al. Anaphylaxis in a food allergy outpatient department: one-year review. Eur Ann Allergy Clin Immunol. 2018;50(2):81–8.  https://doi.org/10.23822/EurAnnACI.1764-1489.45.
  41. 41.
    Jeong K, Lee SY, Ahn K, Kim J, Lee HR, Suh DI, et al. A multicenter study on anaphylaxis caused by peanut, tree nuts, and seeds in children and adolescents. Allergy. 2017;72(3):507–10.  https://doi.org/10.1111/all.13096.
  42. 42.
    Kim SY, Kim MH, Cho YJ. Different clinical features of anaphylaxis according to cause and risk factors for severe reactions. Allergol Int. 2018;67(1):96–102.  https://doi.org/10.1016/j.alit.2017.05.005.CrossRefPubMedGoogle Scholar
  43. 43.
    • Castells M. Diagnosis and management of anaphylaxis in precision medicine. J Allergy Clin Immunol. 2017;140(2):321–33.  https://doi.org/10.1016/j.jaci.2017.06.012. COMMENT: Excellent review of clinical presentation, diagnosis, etiologies, and management of all types of anaphylaxis. CrossRefPubMedGoogle Scholar
  44. 44.
    Krogulska A, Dynowski J, Wasowska-Krolikowska K. Bronchial reactivity in schoolchildren allergic to food. Ann Allergy Asthma Immunol. 2010;105(1):31–8.  https://doi.org/10.1016/j.anai.2010.05.015.CrossRefPubMedGoogle Scholar
  45. 45.
    Kivity S, Fireman E, Sade K. Bronchial hyperactivity, sputum analysis and skin prick test to inhalant allergens in patients with symptomatic food hypersensitivity. Isr Med Assoc J. 2005;7(12):781–4.PubMedGoogle Scholar
  46. 46.
    Asaumi T, Ebisawa M. How to manage food dependent exercise induced anaphylaxis (FDEIA). Curr Opin Allergy Clin Immunol. 2018;18(3):243–7.  https://doi.org/10.1097/ACI.0000000000000442.PubMedCrossRefGoogle Scholar
  47. 47.
    Commins SP, Satinover SM, Hosen J, Mozena J, Borish L, Lewis BD, et al. Delayed anaphylaxis, angioedema, or urticaria after consumption of red meat in patients with IgE antibodies specific for galactose-alpha-1,3-galactose. J Allergy Clin Immunol. 2009;123(2):426–33.  https://doi.org/10.1016/j.jaci.2008.10.052.
  48. 48.
    Commins SP, James HR, Stevens W, Pochan SL, Land MH, King C, et al. Delayed clinical and ex vivo response to mammalian meat in patients with IgE to galactose-alpha-1,3-galactose. J Allergy Clin Immunol. 2014;134(1):108–15.  https://doi.org/10.1016/j.jaci.2014.01.024.CrossRefPubMedPubMedCentralGoogle Scholar
  49. 49.
    Commins SP, Platts-Mills TA. Tick bites and red meat allergy. Curr Opin Allergy Clin Immunol. 2013;13(4):354–9.  https://doi.org/10.1097/ACI.0b013e3283624560.CrossRefPubMedPubMedCentralGoogle Scholar
  50. 50.
    Commins SP, James HR, Kelly LA, Pochan SL, Workman LJ, Perzanowski MS, et al. The relevance of tick bites to the production of IgE antibodies to the mammalian oligosaccharide galactose-alpha-1,3-galactose. J Allergy Clin Immunol. 2011;127(5):1286–93 e6.  https://doi.org/10.1016/j.jaci.2011.02.019.
  51. 51.
    Mabelane T, Botha M, Thomas HF, Levin M. Alpha gal allergy in rural black African subjects associated with a high prevalence of abdominal manifestations and a more rapid onset of symptoms. J Allergy Clin Immunol. 2018;141(Supplement 2):AB200.CrossRefGoogle Scholar
  52. 52.
    Rudders SA, Clark S, Camargo CA Jr. Inpatient interventions are infrequent during pediatric hospitalizations for food-induced anaphylaxis. J Allergy Clin Immunol Pract. 2017;5(5):1421–4 e2.  https://doi.org/10.1016/j.jaip.2017.04.036.CrossRefPubMedPubMedCentralGoogle Scholar
  53. 53.
    Lee S, Bellolio MF, Hess EP, Erwin P, Murad MH, Campbell RL. Time of onset and predictors of biphasic anaphylactic reactions: a systematic review and meta-analysis. J Allergy Clin Immunol Pract. 2015;3(3):408–16 e1-2.  https://doi.org/10.1016/j.jaip.2014.12.010.CrossRefPubMedGoogle Scholar
  54. 54.
    Lee S, Peterson A, Lohse CM, Hess EP, Campbell RL. Further evaluation of factors that may predict biphasic reactions in emergency department anaphylaxis patients. J Allergy Clin Immunol Pract. 2017;5(5):1295–301.  https://doi.org/10.1016/j.jaip.2017.07.020.CrossRefPubMedGoogle Scholar
  55. 55.
    van der Linden PW, Hack CE, Poortman J, Vivie-Kipp YC, Struyvenberg A, van der Zwan JK. Insect-sting challenge in 138 patients: relation between clinical severity of anaphylaxis and mast cell activation. J Allergy Clin Immunol. 1992;90(1):110–8.CrossRefPubMedGoogle Scholar
  56. 56.
    Mertes PM, Alla F, Trechot P, Auroy Y, Jougla E, Groupe d’Etudes des reactions Anaphylactoides P. Anaphylaxis during anesthesia in France: an 8-year national survey. J Allergy Clin Immunol 2011;128(2):366–373. doi: https://doi.org/10.1016/j.jaci.2011.03.003.
  57. 57.
    Yunginger JW, Nelson DR, Squillace DL, Jones RT, Holley KE, Hyma BA, et al. Laboratory investigation of deaths due to anaphylaxis. J Forensic Sci. 1991;36(3):857–65.Google Scholar
  58. 58.
    • Dua S, Dowey J, Foley L, Islam S, King Y, Ewan P, et al. Diagnostic value of tryptase in food allergic reactions: a prospective study of 160 adult peanut challenges. J Allergy Clin Immunol Pract. 2018;  https://doi.org/10.1016/j.jaip.2018.01.006. COMMENT: Prospective evidence that tryptase elevation does occur in food-induced anaphylaxis in adults
  59. 59.
    Komarow HD, Hu Z, Brittain E, Uzzaman A, Gaskins D, Metcalfe DD. Serum tryptase levels in atopic and nonatopic children. J Allergy Clin Immunol. 2009;124(4):845–8.  https://doi.org/10.1016/j.jaci.2009.06.040. CrossRefPubMedPubMedCentralGoogle Scholar
  60. 60.
    Belhocine W, Ibrahim Z, Grandne V, Buffat C, Robert P, Gras D, et al. Total serum tryptase levels are higher in young infants. Pediatr Allergy Immunol. 2011;22(6):600–7.  https://doi.org/10.1111/j.1399-3038.2011.01166.x. CrossRefPubMedGoogle Scholar
  61. 61.
    Sala-Cunill A, Cardona V, Labrador-Horrillo M, Luengo O, Esteso O, Garriga T, et al. Usefulness and limitations of sequential serum tryptase for the diagnosis of anaphylaxis in 102 patients. Int Arch Allergy Immunol. 2013;160(2):192–9.  https://doi.org/10.1159/000339749.
  62. 62.
    Schwartz LB, Irani AM, Roller K, Castells MC, Schechter NM. Quantitation of histamine, tryptase, and chymase in dispersed human T and TC mast cells. J Immunol. 1987;138(8):2611–5.PubMedGoogle Scholar
  63. 63.
    Castells MC, Irani AM, Schwartz LB. Evaluation of human peripheral blood leukocytes for mast cell tryptase. J Immunol. 1987;138(7):2184–9.PubMedGoogle Scholar
  64. 64.
    Sampson HA, Aceves S, Bock SA, James J, Jones S, Lang D, et al. Food allergy: a practice parameter update-2014. J Allergy Clin Immunol. 2014;134(5):1016–25 e43.  https://doi.org/10.1016/j.jaci.2014.05.013.
  65. 65.
    Sporik R, Hill DJ, Hosking CS. Specificity of allergen skin testing in predicting positive open food challenges to milk, egg and peanut in children. Clin Exp Allergy. 2000;30(11):1540–6.CrossRefPubMedGoogle Scholar
  66. 66.
    Knight AK, Shreffler WG, Sampson HA, Sicherer SH, Noone S, Mofidi S, et al. Skin prick test to egg white provides additional diagnostic utility to serum egg white-specific IgE antibody concentration in children. J Allergy Clin Immunol. 2006;117(4):842–7.  https://doi.org/10.1016/j.jaci.2005.12.1304. CrossRefPubMedGoogle Scholar
  67. 67.
    Roberts G, Lack G. Diagnosing peanut allergy with skin prick and specific IgE testing. J Allergy Clin Immunol. 2005;115(6):1291–6.  https://doi.org/10.1016/j.jaci.2005.02.038. CrossRefPubMedGoogle Scholar
  68. 68.
    Sicherer SH, Morrow EH, Sampson HA. Dose-response in double-blind, placebo-controlled oral food challenges in children with atopic dermatitis. J Allergy Clin Immunol. 2000;105(3):582–6.  https://doi.org/10.1067/mai.2000.104941. CrossRefPubMedGoogle Scholar
  69. 69.
    Boyano-Martinez T, Garcia-Ara C, Diaz-Pena JM, Martin-Esteban M. Prediction of tolerance on the basis of quantification of egg white-specific IgE antibodies in children with egg allergy. J Allergy Clin Immunol. 2002;110(2):304–9.CrossRefPubMedGoogle Scholar
  70. 70.
    Perry TT, Matsui EC, Kay Conover-Walker M, Wood RA. The relationship of allergen-specific IgE levels and oral food challenge outcome. J Allergy Clin Immunol. 2004;114(1):144–9.  https://doi.org/10.1016/j.jaci.2004.04.009. CrossRefPubMedGoogle Scholar
  71. 71.
    Sampson HA. Utility of food-specific IgE concentrations in predicting symptomatic food allergy. J Allergy Clin Immunol. 2001;107(5):891–6.  https://doi.org/10.1067/mai.2001.114708. CrossRefPubMedGoogle Scholar
  72. 72.
    Garcia-Ara C, Boyano-Martinez T, Diaz-Pena JM, Martin-Munoz F, Reche-Frutos M, Martin-Esteban M. Specific IgE levels in the diagnosis of immediate hypersensitivity to cows’ milk protein in the infant. J Allergy Clin Immunol. 2001;107(1):185–90.CrossRefPubMedGoogle Scholar
  73. 73.
    Bird JA, Crain M, Varshney P. Food allergen panel testing often results in misdiagnosis of food allergy. J Pediatr. 2015;166(1):97–100.  https://doi.org/10.1016/j.jpeds.2014.07.062.CrossRefPubMedGoogle Scholar
  74. 74.
    Santos AF, Douiri A, Becares N, Wu SY, Stephens A, Radulovic S, et al. Basophil activation test discriminates between allergy and tolerance in peanut-sensitized children. J Allergy Clin Immunol. 2014;134(3):645–52.  https://doi.org/10.1016/j.jaci.2014.04.039. CrossRefPubMedPubMedCentralGoogle Scholar
  75. 75.
    Nicolaou N, Poorafshar M, Murray C, Simpson A, Winell H, Kerry G, Härlin A, Woodcock A, Ahlstedt S, Custovic A Allergy or tolerance in children sensitized to peanut: prevalence and differentiation using component-resolved diagnostics. J Allergy Clin Immunol 2010;125(1):191–7 e1–13.  https://doi.org/10.1016/j.jaci.2009.10.008, 197.e13.
  76. 76.
    Santos AF, Couto-Francisco N, Becares N, Kwok M, Bahnson HT, Lack G. A novel human mast cell activation test for peanut allergy. J Allergy Clin Immunol 2018.  https://doi.org/10.1016/j.jaci.2018.03.011.
  77. 77.
    • Bahri R, Custovic A, Korosec P, Tsoumani M, Barron M, Wu J, et al. Mast cell activation test in the diagnosis of allergic disease and anaphylaxis. J Allergy Clin Immunol. 2018;  https://doi.org/10.1016/j.jaci.2018.01.043. COMMENT: Along with Santos et al, first reports of mast cell activation assay for use in diagnosis of food allergy.
  78. 78.
    •• Deak PE, Vrabel MR, Kiziltepe T, Bilgicer B. Determination of crucial immunogenic epitopes in major peanut allergy protein, Ara h2, via novel nanoallergen platform. Sci Rep. 2017;7(1):3981.  https://doi.org/10.1038/s41598-017-04268-6. COMMENT: New diagnostic tool that identifies allergens at the epitope level. CrossRefPubMedPubMedCentralGoogle Scholar
  79. 79.
    Nowak-Wegrzyn A, Assa’ad AH, Bahna SL, bock SA, Sicherer SH, Teuber SS et al. Work Group report: oral food challenge testing. J Allergy Clin Immunol 2009;123(6 Suppl):S365–S383.  https://doi.org/10.1016/j.jaci.2009.03.042.
  80. 80.
    Togias A, Cooper SF, Acebal ML, Assa’ad A, Baker JR, Jr., Beck LA et al. Addendum guidelines for the prevention of peanut allergy in the United States: report of the National Institute of Allergy and Infectious Diseases-sponsored expert panel. J Allergy Clin Immunol 2017;139(1):29–44.  https://doi.org/10.1016/j.jaci.2016.10.010.
  81. 81.
    Du Toit G, Roberts G, Sayre PH, Bahnson HT, Radulovic S, Santos AF, et al. Randomized trial of peanut consumption in infants at risk for peanut allergy. N Engl J Med. 2015;372(9):803–13.  https://doi.org/10.1056/NEJMoa1414850. CrossRefPubMedPubMedCentralGoogle Scholar
  82. 82.
    Bird JA, Groetch M, Allen KJ, Bock SA, Leonard S, Nowak-Wegrzyn AH, et al. Conducting an oral food challenge to peanut in an infant. J Allergy Clin Immunol Pract. 2016;5:301–311.e1.  https://doi.org/10.1016/j.jaip.2016.07.019.
  83. 83.
    Sampson HA, Gerth van Wijk R, Bindslev-Jensen C, Sicherer S, Teuber SS, Burks AW, et al. Standardizing double-blind, placebo-controlled oral food challenges: American Academy of Allergy, Asthma & Immunology-European Academy of Allergy and Clinical Immunology PRACTALL consensus report. J Allergy Clin Immunol. 2012;130(6):1260–74.  https://doi.org/10.1016/j.jaci.2012.10.017.
  84. 84.
    Kansen HM, Le TM, Meijer Y, Flokstra-de Blok BMJ, Welsing PMJ, van der Ent CK, et al. The impact of oral food challenges for food allergy on quality of life: a systematic review. Pediatr Allergy Immunol. 2018;  https://doi.org/10.1111/pai.12905.
  85. 85.
    • College of Allergy AIAAoA. Statement by the American College of Allergy AIAAoA, Asthma & Immunology; and the Canadian Society of Allergy and Clinical Immunology. Allergists respond to death of 3 year-old boy during oral food challenge. 2017. COMMENT: Statement regarding the only reported death due to FIA after OFC.Google Scholar
  86. 86.
    Cianferoni A, Khullar K, Saltzman R, Fiedler J, Garrett JP, Naimi DR, et al. Oral food challenge to wheat: a near-fatal anaphylaxis and review of 93 food challenges in children. World Allergy Organ J. 2013;6(1):14–0.  https://doi.org/10.1186/1939-4551-6-14.
  87. 87.
    Perry TT, Matsui EC, Conover-Walker MK, Wood RA. Risk of oral food challenges. J Allergy Clin Immunol. 2004;114(5):1164–8.  https://doi.org/10.1016/j.jaci.2004.07.063. CrossRefPubMedGoogle Scholar
  88. 88.
    • Virkud YV, Burks AW, Steele PH, Edwards LJ, Berglund JP, Jones SM, et al. Novel baseline predictors of adverse events during oral immunotherapy in children with peanut allergy. J Allergy Clin Immunol. 2017;139(3):882–8 e5.  https://doi.org/10.1016/j.jaci.2016.07.030. COMMENT: Largest study to date on adverse effects associated with OIT, identified new risk factors including allergic rhinitis.
  89. 89.
    Yanagida N, Sato S, Asaumi T, Ogura K, Ebisawa M. Risk factors for severe reactions during double-blind placebo-controlled food challenges. Int Arch Allergy Immunol. 2017;172(3):173–82.  https://doi.org/10.1159/000458724. CrossRefPubMedPubMedCentralGoogle Scholar
  90. 90.
    Song Y, Wang J, Leung N, Wang LX, Lisann L, Sicherer SH, et al. Correlations between basophil activation, allergen-specific IgE with outcome and severity of oral food challenges. Annals of allergy, asthma & immunology: official publication of the American College of Allergy, Asthma, & Immunology. 2015;114(4):319–26.  https://doi.org/10.1016/j.anai.2015.01.006.
  91. 91.
    Shreffler WG, Beyer K, Chu TH, Burks AW, Sampson HA. Microarray immunoassay: association of clinical history, in vitro IgE function, and heterogeneity of allergenic peanut epitopes. J Allergy Clin Immunol. 2004;113(4):776–82.  https://doi.org/10.1016/j.jaci.2003.12.588. CrossRefPubMedGoogle Scholar
  92. 92.
    Vickery BP, Beyer K, Burks AW, Casale T, Hourihane J, Jones S, et al. Outcome of 583 entry double-blind placebo-controlled peanut challenges during screening for the palisade phase 3 oral immunotherapy trial. J Allergy Clin Immunol. 2017;139(2, Supplement):AB381.CrossRefGoogle Scholar
  93. 93.
    Pettersson ME, Koppelman GH, Flokstra-de Blok BMJ, Kollen BJ, Dubois AEJ. Prediction of the severity of allergic reactions to foods. Allergy. 2018;  https://doi.org/10.1111/all.13423.
  94. 94.
    Santos AF, Du Toit G, Douiri A, Radulovic S, Stephens A, Turcanu V, et al. Distinct parameters of the basophil activation test reflect the severity and threshold of allergic reactions to peanut. J Allergy Clin Immunol. 2015;135(1):179–86.  https://doi.org/10.1016/j.jaci.2014.09.001. CrossRefPubMedPubMedCentralGoogle Scholar
  95. 95.
    Ocmant A, Mulier S, Hanssens L, Goldman M, Casimir G, Mascart F, et al. Basophil activation tests for the diagnosis of food allergy in children. Clinical and experimental allergy: journal of the British Society for Allergy and Clinical Immunology. 2009;39(8):1234–45.  https://doi.org/10.1111/j.1365-2222.2009.03292.x.
  96. 96.
    Reier-Nilsen T, Michelsen MM, Lodrup Carlsen KC, Carlsen KH, Mowinckel P, Nygaard UC, et al. Predicting reactivity threshold in children with anaphylaxis to peanut. Clinical and experimental allergy: journal of the British Society for Allergy and Clinical Immunology. 2018;48(4):415–23.  https://doi.org/10.1111/cea.13078.CrossRefGoogle Scholar
  97. 97.
    Sugiura S, Sasaki K, Matsui T, Nakagawa T, Kando N, Ito K. Development of a prediction model for a severe reaction in cow’s milk challenges. Allergol Int. 2017;66(3):493–4.  https://doi.org/10.1016/j.alit.2016.11.005.CrossRefPubMedGoogle Scholar
  98. 98.
    Sugiura S, Matsui T, Nakagawa T, Sasaki K, Nakata J, Kando N, et al. Development of a prediction model of severe reaction in boiled egg challenges. Allergol Int. 2016;65(3):293–9.  https://doi.org/10.1016/j.alit.2016.01.005.
  99. 99.
    Sugiura S, Matsui T, Furuta T, Sasaki K, Kando N, Ito K. Development of a prediction model for severe wheat allergy. Pediatr Allergy Immunol. 2018;29(1):93–6.  https://doi.org/10.1111/pai.12806.CrossRefPubMedGoogle Scholar
  100. 100.
    Chinthrajah RS, Purington N, Andorf S, Rosa JS, Mukai K, Hamilton R, et al. Development of a tool predicting severity of allergic reaction during peanut challenge. Ann Allergy Asthma Immunol. 2018;  https://doi.org/10.1016/j.anai.2018.04.020.
  101. 101.
    Blumchen K, Beder A, Beschorner J, Ahrens F, Gruebl A, Hamelmann E, et al. Modified oral food challenge used with sensitization biomarkers provides more real-life clinical thresholds for peanut allergy. J Allergy Clin Immunol. 2014;134(2):390–8.  https://doi.org/10.1016/j.jaci.2014.03.035.
  102. 102.
    Dubois AEJ, Turner PJ, Hourihane J, Ballmer-Weber B, Beyer K, Chan CH, et al. How does dose impact on the severity of food-induced allergic reactions, and can this improve risk assessment for allergenic foods?: report from an ILSI Europe Food Allergy Task Force Expert Group and Workshop. Allergy. 2018;  https://doi.org/10.1111/all.13405.
  103. 103.
    Simons FE, Ardusso LR, Bilo MB, El-Gamal YM, Ledford DK, Ring J, et al. World allergy organization guidelines for the assessment and management of anaphylaxis. World Allergy Organ J. 2011;4(2):13–37.  https://doi.org/10.1097/WOX.0b013e318211496c.CrossRefPubMedPubMedCentralGoogle Scholar
  104. 104.
    Kemp SF, Lockey RF, Simons FE, World Allergy Organization ad hoc Committee on Epinephrine in A. Epinephrine: the drug of choice for anaphylaxis. A statement of the World Allergy Organization. Allergy 2008;63(8):1061–1070. doi: https://doi.org/10.1111/j.1398-9995.2008.01733.x.
  105. 105.
    Lieberman P, Nicklas RA, Randolph C, Oppenheimer J, Bernstein D, Bernstein J, et al. Anaphylaxis––a practice parameter update 2015. Ann Allergy Asthma Immunol. 2015;115(5):341–84.  https://doi.org/10.1016/j.anai.2015.07.019.
  106. 106.
    Muraro A, Roberts G, Worm M, Bilo MB, Brockow K, Fernandez Rivas M, et al. Anaphylaxis: guidelines from the European Academy of Allergy and Clinical Immunology. Allergy. 2014;69(8):1026–45.  https://doi.org/10.1111/all.12437.CrossRefPubMedGoogle Scholar
  107. 107.
    Simons FE, Anaphylaxis SHA. Unique aspects of clinical diagnosis and management in infants (birth to age 2 years). J Allergy Clin Immunol. 2015;135(5):1125–31.  https://doi.org/10.1016/j.jaci.2014.09.014. CrossRefPubMedGoogle Scholar
  108. 108.
    Bautista E, Simons FE, Simons KJ, Becker AB, Duke K, Tillett M, et al. Epinephrine fails to hasten hemodynamic recovery in fully developed canine anaphylactic shock. Int Arch Allergy Immunol. 2002;128(2):151–64.  https://doi.org/10.1159/000059406.CrossRefPubMedGoogle Scholar
  109. 109.
    Cardona V, Ferre-Ybarz L, Guilarte M, Moreno-Perez N, Gomez-Galan C, Alcoceba-Borras E, et al. Safety of adrenaline use in anaphylaxis: a multicentre register. Int Arch Allergy Immunol. 2017;173(3):171–7.  https://doi.org/10.1159/000477566.CrossRefPubMedGoogle Scholar
  110. 110.
    Nazir S, Lohani S, Tachamo N, Ghimire S, Poudel DR, Donato A. Takotsubo cardiomyopathy associated with epinephrine use: a systematic review and meta-analysis. Int J Cardiol. 2017;229:67–70.  https://doi.org/10.1016/j.ijcard.2016.11.266.CrossRefPubMedGoogle Scholar
  111. 111.
    Jayamali WD, Herath H, Kulathunga A. Myocardial infarction during anaphylaxis in a young healthy male with normal coronary arteries––is epinephrine the culprit? BMC Cardiovasc Disord. 2017;17(1):237.  https://doi.org/10.1186/s12872-017-0670-7. CrossRefPubMedPubMedCentralGoogle Scholar
  112. 112.
    Memon S, Chhabra L, Masrur S, Parker MW. Allergic acute coronary syndrome (Kounis syndrome). Proc (Bayl Univ Med Cent). 2015;28(3):358–62.CrossRefGoogle Scholar
  113. 113.
    Campbell RL, Bellolio MF, Knutson BD, Bellamkonda VR, Fedko MG, Nestler DM, et al. Epinephrine in anaphylaxis: higher risk of cardiovascular complications and overdose after administration of intravenous bolus epinephrine compared with intramuscular epinephrine. J Allergy Clin Immunol Pract. 2015;3(1):76–80.  https://doi.org/10.1016/j.jaip.2014.06.007.
  114. 114.
    Shaker M, Toy D, Lindholm C, Low J, Reigh E, Greenhawt M. Summary and simulation of reported adverse events from epinephrine autoinjectors and a review of the literature. J Allergy Clin Immunol Pract. 2018;  https://doi.org/10.1016/j.jaip.2018.04.006.
  115. 115.
    Lazar I, Cavari Y, Levitas A, Mandolla AB, Broides A. Gastric drainage in the treatment of near-fatal food-induced anaphylaxis. Pediatr Emerg Care. 2017:1.  https://doi.org/10.1097/PEC.0000000000001293.
  116. 116.
    Motosue MS, Bellolio MF, Van Houten HK, Shah ND, Bellamkonda VR, Nestler DM, et al. Temporal trends in epinephrine dispensing and allergy/immunology follow-up among emergency department anaphylaxis patients in the United States, 2005–2014. J Allergy Clin Immunol Pract. 2017;5(5):1272–9 e1.  https://doi.org/10.1016/j.jaip.2017.06.009.CrossRefPubMedGoogle Scholar
  117. 117.
    Brown J, Tuthill D, Alfaham M, Spear E. A randomized maternal evaluation of epinephrine autoinjection devices. Pediatr Allergy Immunol 2013;24(2):173–177.  https://doi.org/10.1111/pai.12048.
  118. 118.
    Arga M, Bakirtas A, Catal F, Derinoz O, Harmanci K, Razi CH, et al. Training of trainers on epinephrine autoinjector use. Pediatr Allergy Immunol. 2011;22(6):590–3.  https://doi.org/10.1111/j.1399-3038.2011.01143.x.
  119. 119.
    Patel DR, Upton JEM, Wang J, Harada L, Guffey D, Minard CG, et al. Quality of life for parents of children with food allergy in peanut-restricted versus peanut-free schools in the United States and Canada. J Allergy Clin Immunol Pract. 2018;6(2):671–3 e7.  https://doi.org/10.1016/j.jaip.2017.08.013.
  120. 120.
    •• Baumert JL, Taylor SL, Koppelman SJ. Quantitative assessment of the safety benefits associated with increasing clinical peanut thresholds through immunotherapy. J Allergy Clin Immunol Pract. 2018;6(2):457–65 e4.  https://doi.org/10.1016/j.jaip.2017.05.006. COMMENT: Quantifies the real-life benefits of the desensitization provided by immunotherapy methods currently being investigated.
  121. 121.
    Bird JA, Spergel JM, Jones SM, Rachid R, Assa'ad AH, Wang J, et al. Efficacy and safety of AR101 in oral immunotherapy for peanut allergy: results of ARC001, a randomized, double-blind, placebo-controlled phase 2 clinical trial. J Allergy Clin Immunol Pract. 2018;6(2):476–85 e3.  https://doi.org/10.1016/j.jaip.2017.09.016.
  122. 122.
    Factor JM, Mendelson L, Lee J, Nouman G, Lester MR. Effect of oral immunotherapy to peanut on food-specific quality of life. Ann Allergy Asthma Immunol. 2012;109(5):348–52 e2.  https://doi.org/10.1016/j.anai.2012.08.015.CrossRefPubMedGoogle Scholar
  123. 123.
    Epstein-Rigbi N, Goldberg MR, Levy MB, Nachshon L, Elizur A. Changes in quality of life of food-allergic children from initiation of oral immunotherapy, through up-dosing, upon reaching maintenance and after 6 months of follow-up. J Allergy Clin Immunol. 2018;141(Supplement 2):AB240.CrossRefGoogle Scholar
  124. 124.
    Shaker MS. An economic analysis of a peanut oral immunotherapy study in children. J Allergy Clin Immunol Pract. 2017;5:1707–16.  https://doi.org/10.1016/j.jaip.2017.04.016.CrossRefPubMedGoogle Scholar
  125. 125.
    De Schryver S, Clarke A, La Vieille S, Eisman H, Morris J, Lim R, et al. Food-induced anaphylaxis to a known food allergen in children often occurs despite adult supervision. Pediatr Allergy Immunol. 2017;28(7):715–7.  https://doi.org/10.1111/pai.12770. CrossRefPubMedGoogle Scholar
  126. 126.
    Shaker MS, Corbin D, Shaker M, Shaker S. Cost-effectiveness of bystander epinephrine in community anaphylaxis. J Allergy Clin Immunol. 2018;141(Supplement 2):AB65.CrossRefGoogle Scholar
  127. 127.
    Sole D, Ivancevich JC, Borges MS, Coelho MA, Rosario NA, Ardusso LR, et al. Anaphylaxis in Latin America: a report of the online Latin American survey on anaphylaxis (OLASA). Clinics (Sao Paulo). 2011;66(6):943–7.Google Scholar
  128. 128.
    Alvarez-Perea A, Tomas-Perez M, Martinez-Lezcano P, Marco G, Perez D, Zubeldia JM, et al. Anaphylaxis in adolescent/adult patients treated in the emergency department: differences between initial impressions and the definitive diagnosis. J Investig Allergol Clin Immunol. 2015;25(4):288–94.PubMedGoogle Scholar
  129. 129.
    Beyer K, Eckermann O, Hompes S, Grabenhenrich L, Worm M. Anaphylaxis in an emergency setting––elicitors, therapy and incidence of severe allergic reactions. Allergy. 2012;67(11):1451–6.  https://doi.org/10.1111/all.12012.CrossRefPubMedGoogle Scholar
  130. 130.
    Worm M, Eckermann O, Dolle S, Aberer W, Beyer K, Hawranek T, et al. Triggers and treatment of anaphylaxis: an analysis of 4,000 cases from Germany. Austria and Switzerland Dtsch Arztebl Int. 2014;111(21):367–75.  https://doi.org/10.3238/arztebl.2014.0367. PubMedCrossRefGoogle Scholar
  131. 131.
    Hitti EA, Zaitoun F, Harmouche E, Saliba M, Mufarrij A. Acute allergic reactions in the emergency department: characteristics and management practices. Eur J Emerg Med. 2015;22(4):253–9.  https://doi.org/10.1097/MEJ.0000000000000155.CrossRefPubMedGoogle Scholar
  132. 132.
    Robinson M, Greenhawt M, Stukus DR. Factors associated with epinephrine administration for anaphylaxis in children before arrival to the emergency department. Annals of allergy, asthma & immunology: official publication of the American College of Allergy, Asthma, & Immunology. 2017;119(2):164–9.  https://doi.org/10.1016/j.anai.2017.06.001.CrossRefGoogle Scholar
  133. 133.
    Lee AY, Enarson P, Clarke AE, La Vieille S, Eisman H, Chan ES, et al. Anaphylaxis across two Canadian pediatric centers: evaluating management disparities. J Asthma Allergy. 2017;10:1–7.  https://doi.org/10.2147/JAA.S123053. CrossRefPubMedGoogle Scholar
  134. 134.
    Noone S, Ross J, Sampson HA, Wang J. Epinephrine use in positive oral food challenges performed as a screening test for food allergy therapy trials. J Allergy Clin Immunol Pract. 2015;3(3):424–8.  https://doi.org/10.1016/j.jaip.2014.10.008.CrossRefPubMedPubMedCentralGoogle Scholar
  135. 135.
    van der Valk JPM, Berends I, Gerth van Wijk R, Arends NJT, van Maaren MS, de Groot H, et al. Small percentage of anaphylactic reactions treated with epinephrine during food challenges in Dutch children. Annals of allergy, asthma & immunology: official publication of the American College of Allergy, Asthma, & Immunology. 2018;120(3):300–3.  https://doi.org/10.1016/j.anai.2017.08.018.
  136. 136.
    Varshney P, Jones SM, Scurlock AM, Perry TT, Kemper A, Steele P, et al. A randomized controlled study of peanut oral immunotherapy: clinical desensitization and modulation of the allergic response. J Allergy Clin Immunol. 2011;127(3):654–60.  https://doi.org/10.1016/j.jaci.2010.12.1111.
  137. 137.
    Clark AT, Islam S, King Y, Deighton J, Anagnostou K, Ewan PW. Successful oral tolerance induction in severe peanut allergy. Allergy. 2009;64(8):1218–20.  https://doi.org/10.1111/j.1398-9995.2009.01982.x.CrossRefPubMedGoogle Scholar
  138. 138.
    Anagnostou K, Islam S, King Y, Foley L, Pasea L, Bond S, et al. Assessing the efficacy of oral immunotherapy for the desensitisation of peanut allergy in children (STOP II): a phase 2 randomised controlled trial. Lancet. 2014;383(9925):1297–304.  https://doi.org/10.1016/s0140-6736(13)62301-6.
  139. 139.
    Yu GP, Weldon B, Neale-May S, Nadeau KC. The safety of peanut oral immunotherapy in peanut-allergic subjects in a single-center trial. Int Arch Allergy Immunol. 2012;159(2):179–82.  https://doi.org/10.1159/000336391.CrossRefPubMedPubMedCentralGoogle Scholar
  140. 140.
    Zigmont E, Zawadzki R, Beyer K, Burks AW, Casale T, Hourihane J, et al. International comparisons of patient characteristics in a phase 3 study of AR101 for peanut allergy. Annals of allergy, asthma & immunology: official publication of the American College of Allergy, Asthma, & Immunology. 2017;119(5, Supplement S):S81.Google Scholar
  141. 141.
    Fleischer DM, Perry TT, Atkins D, Wood RA, Burks AW, Jones SM, et al. Allergic reactions to foods in preschool-aged children in a prospective observational food allergy study. Pediatrics. 2012;130(1):e25–32.  https://doi.org/10.1542/peds.2011-1762.
  142. 142.
    Soller L, Teoh T, Baerg I, Gonzalez T, Wong T, Hildebrand KJ, et al. Supervised epinephrine autoinjector administration in a cohort of children with anaphylaxis during oral food challenges (OFCs). J Allergy Clin Immunol. 2018;141(Supplement 2):AB252.Google Scholar
  143. 143.
    Ruiz-Baques A, Contreras-Porta J, Marques-Mejias M, Cardenas Rebollo JM, Capel Torres F, Arino Pla MN, et al. Evaluation of an online educational program for parents and caregivers of children with food allergies. J Investig Allergol Clin Immunol. 2018;28(1):37–41.  https://doi.org/10.18176/jiaci.0214.CrossRefPubMedGoogle Scholar
  144. 144.
    Alvarez-Perea A, Cabrera-Freitag P, Fuentes-Aparicio V, Infante S, Zapatero L, Zubeldia JM. Social media as a tool for the management of food allergy in children. J Investig Allergol Clin Immunol. 2018;0  https://doi.org/10.18176/jiaci.0235.
  145. 145.
    Neupert K, Kunnel S, Freeman S, Pont S, Varshney P. Epinephrine use in Austin Independent School District (AISD) schools after implementation of unassigned epinephrine. J Allergy Clin Immunol. 2018;141(Supplement 2):AB146.CrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC, part of Springer Nature 2018

Authors and Affiliations

  1. 1.Department of Pediatrics and Internal Medicine, Division of Allergy and ImmunologyUniversity of Texas Southwestern Medical SchoolDallasUSA
  2. 2.Department of PediatricsUniversity of Texas Southwestern Medical SchoolDallasUSA

Personalised recommendations